Efstathios Papavassiliou, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hematoma, Subdural, Chronic | 7 | 2023 | 90 | 1.250 |
Why?
|
| Decompression, Surgical | 2 | 2019 | 594 | 0.890 |
Why?
|
| Spinal Fusion | 3 | 2023 | 1241 | 0.860 |
Why?
|
| Lumbar Vertebrae | 3 | 2020 | 1848 | 0.840 |
Why?
|
| Subthalamic Nucleus | 6 | 2014 | 184 | 0.700 |
Why?
|
| Peripheral Nervous System Neoplasms | 1 | 2020 | 122 | 0.690 |
Why?
|
| Internal Fixators | 1 | 2019 | 188 | 0.660 |
Why?
|
| Spinal Diseases | 2 | 2020 | 538 | 0.640 |
Why?
|
| Spinal Cord Neoplasms | 1 | 2020 | 281 | 0.600 |
Why?
|
| Deep Brain Stimulation | 9 | 2020 | 748 | 0.580 |
Why?
|
| Bone Screws | 1 | 2020 | 520 | 0.570 |
Why?
|
| Arachnoid Cysts | 1 | 2016 | 59 | 0.550 |
Why?
|
| Foreign Bodies | 1 | 2019 | 400 | 0.520 |
Why?
|
| Thoracic Vertebrae | 1 | 2020 | 608 | 0.520 |
Why?
|
| Shoulder Pain | 1 | 2016 | 144 | 0.500 |
Why?
|
| Spinal Cord Compression | 1 | 2016 | 235 | 0.500 |
Why?
|
| Arnold-Chiari Malformation | 1 | 2016 | 154 | 0.470 |
Why?
|
| Spinal Cord Diseases | 1 | 2016 | 298 | 0.460 |
Why?
|
| Muscle Weakness | 1 | 2016 | 413 | 0.430 |
Why?
|
| Muscular Atrophy | 1 | 2016 | 347 | 0.430 |
Why?
|
| Spine | 1 | 2019 | 1144 | 0.430 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2020 | 1100 | 0.430 |
Why?
|
| Universities | 1 | 2016 | 951 | 0.370 |
Why?
|
| Surgical Wound Infection | 1 | 2019 | 1540 | 0.360 |
Why?
|
| Krukenberg Tumor | 1 | 2009 | 16 | 0.350 |
Why?
|
| Essential Tremor | 3 | 2014 | 130 | 0.330 |
Why?
|
| Parkinson Disease | 6 | 2014 | 2775 | 0.310 |
Why?
|
| Athletes | 1 | 2016 | 1093 | 0.310 |
Why?
|
| Preoperative Care | 1 | 2016 | 2251 | 0.300 |
Why?
|
| Pneumoperitoneum, Artificial | 2 | 2015 | 40 | 0.260 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2014 | 3326 | 0.240 |
Why?
|
| Electric Stimulation Therapy | 2 | 2014 | 605 | 0.240 |
Why?
|
| Thalamus | 2 | 2013 | 1023 | 0.230 |
Why?
|
| Intracranial Pressure | 2 | 2015 | 326 | 0.210 |
Why?
|
| Embolization, Therapeutic | 2 | 2022 | 1392 | 0.210 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 2009 | 1381 | 0.200 |
Why?
|
| Stomach Neoplasms | 2 | 2009 | 1332 | 0.200 |
Why?
|
| Hematoma, Subdural, Spinal | 1 | 2020 | 8 | 0.190 |
Why?
|
| Electrodes, Implanted | 4 | 2020 | 824 | 0.180 |
Why?
|
| Cauda Equina | 1 | 2020 | 42 | 0.180 |
Why?
|
| Hematoma, Epidural, Spinal | 1 | 2020 | 36 | 0.180 |
Why?
|
| Lateral Ventricles | 1 | 2021 | 147 | 0.180 |
Why?
|
| Cephalometry | 1 | 2021 | 382 | 0.170 |
Why?
|
| Dyskinesias | 2 | 2011 | 78 | 0.160 |
Why?
|
| Head Injuries, Penetrating | 1 | 2018 | 28 | 0.160 |
Why?
|
| Postoperative Complications | 2 | 2023 | 15297 | 0.160 |
Why?
|
| Peptic Ulcer | 1 | 1999 | 223 | 0.160 |
Why?
|
| Retrospective Studies | 17 | 2023 | 77460 | 0.160 |
Why?
|
| Drainage | 2 | 2023 | 1142 | 0.150 |
Why?
|
| Genes, MHC Class I | 3 | 1996 | 258 | 0.150 |
Why?
|
| Paresis | 1 | 2019 | 179 | 0.150 |
Why?
|
| Aged | 23 | 2023 | 163288 | 0.150 |
Why?
|
| Debridement | 1 | 2019 | 492 | 0.150 |
Why?
|
| Neurosurgical Procedures | 2 | 2018 | 2002 | 0.140 |
Why?
|
| Thoracic Cavity | 1 | 2015 | 13 | 0.140 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2017 | 35425 | 0.140 |
Why?
|
| Ventriculoperitoneal Shunt | 2 | 2015 | 194 | 0.140 |
Why?
|
| Skull | 1 | 2021 | 814 | 0.140 |
Why?
|
| False Negative Reactions | 1 | 2016 | 588 | 0.130 |
Why?
|
| Periosteum | 1 | 2016 | 138 | 0.130 |
Why?
|
| Cervical Vertebrae | 2 | 2023 | 976 | 0.130 |
Why?
|
| Intracranial Hypotension | 1 | 2015 | 41 | 0.130 |
Why?
|
| Inhalation | 1 | 2015 | 143 | 0.130 |
Why?
|
| Pressure | 2 | 2015 | 1203 | 0.130 |
Why?
|
| Aging | 1 | 2014 | 8664 | 0.130 |
Why?
|
| Middle Aged | 24 | 2021 | 213390 | 0.120 |
Why?
|
| Insufflation | 1 | 2014 | 65 | 0.120 |
Why?
|
| Humans | 43 | 2023 | 744366 | 0.120 |
Why?
|
| Colonic Neoplasms | 6 | 1998 | 2542 | 0.110 |
Why?
|
| Ventral Thalamic Nuclei | 1 | 2013 | 41 | 0.110 |
Why?
|
| Sodium Chloride | 1 | 2015 | 625 | 0.110 |
Why?
|
| Reoperation | 2 | 2019 | 4201 | 0.110 |
Why?
|
| Laparoscopy | 2 | 2015 | 2150 | 0.110 |
Why?
|
| Breast Neoplasms | 1 | 2020 | 20824 | 0.110 |
Why?
|
| Verbal Behavior | 1 | 2014 | 339 | 0.110 |
Why?
|
| Wounds, Gunshot | 1 | 2018 | 563 | 0.110 |
Why?
|
| Diagnosis, Differential | 3 | 2016 | 12961 | 0.110 |
Why?
|
| Meningeal Arteries | 2 | 2022 | 61 | 0.100 |
Why?
|
| Ovarian Neoplasms | 1 | 2009 | 4839 | 0.100 |
Why?
|
| Tremor | 1 | 2013 | 175 | 0.100 |
Why?
|
| Meningitis | 1 | 2013 | 216 | 0.100 |
Why?
|
| Propensity Score | 3 | 2023 | 1781 | 0.100 |
Why?
|
| Male | 24 | 2021 | 350115 | 0.100 |
Why?
|
| Female | 23 | 2021 | 380193 | 0.090 |
Why?
|
| Treatment Outcome | 11 | 2023 | 63107 | 0.090 |
Why?
|
| Spinal Fractures | 1 | 2017 | 696 | 0.090 |
Why?
|
| Radiation Protection | 1 | 2014 | 419 | 0.090 |
Why?
|
| Activities of Daily Living | 1 | 2019 | 2419 | 0.090 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2023 | 3070 | 0.090 |
Why?
|
| Melanocytes | 1 | 2013 | 515 | 0.090 |
Why?
|
| Parkinsonian Disorders | 1 | 2013 | 275 | 0.090 |
Why?
|
| Carbon Dioxide | 1 | 2014 | 1150 | 0.090 |
Why?
|
| Cohort Studies | 3 | 2023 | 40559 | 0.080 |
Why?
|
| Time Factors | 3 | 2020 | 40075 | 0.080 |
Why?
|
| Brain Abscess | 1 | 2009 | 118 | 0.080 |
Why?
|
| Histocompatibility Antigens Class I | 4 | 1996 | 1366 | 0.080 |
Why?
|
| Adult | 16 | 2021 | 214052 | 0.080 |
Why?
|
| Aged, 80 and over | 11 | 2021 | 57776 | 0.080 |
Why?
|
| Treatment Failure | 1 | 2014 | 2618 | 0.080 |
Why?
|
| Ethanol | 1 | 1994 | 1342 | 0.080 |
Why?
|
| Risk Factors | 5 | 2020 | 72296 | 0.070 |
Why?
|
| Radiation Injuries | 1 | 2014 | 1180 | 0.070 |
Why?
|
| Sensitivity and Specificity | 3 | 2017 | 14723 | 0.060 |
Why?
|
| Chronic Disease | 3 | 2016 | 9145 | 0.060 |
Why?
|
| Prognosis | 3 | 2020 | 29060 | 0.060 |
Why?
|
| Anti-Bacterial Agents | 2 | 2019 | 7182 | 0.060 |
Why?
|
| Meningeal Neoplasms | 1 | 2013 | 1241 | 0.060 |
Why?
|
| Migraine Disorders | 1 | 2016 | 1620 | 0.060 |
Why?
|
| Motor Activity | 1 | 2014 | 2715 | 0.060 |
Why?
|
| Gene Expression Regulation, Neoplastic | 4 | 1996 | 8432 | 0.060 |
Why?
|
| Brain Injuries | 1 | 2014 | 2029 | 0.050 |
Why?
|
| Diskectomy | 1 | 2023 | 206 | 0.050 |
Why?
|
| Adenocarcinoma | 4 | 1996 | 6364 | 0.050 |
Why?
|
| Bone Wires | 1 | 2020 | 122 | 0.050 |
Why?
|
| Algorithms | 1 | 2021 | 13882 | 0.050 |
Why?
|
| Greece | 1 | 1999 | 344 | 0.040 |
Why?
|
| Reproducibility of Results | 2 | 2014 | 19905 | 0.040 |
Why?
|
| Young Adult | 4 | 2021 | 56429 | 0.040 |
Why?
|
| Atlanto-Occipital Joint | 1 | 2017 | 33 | 0.040 |
Why?
|
| Atlanto-Axial Joint | 1 | 2017 | 61 | 0.040 |
Why?
|
| Cephaloridine | 1 | 2016 | 7 | 0.040 |
Why?
|
| Receptors, Interleukin-1 Type II | 1 | 2016 | 11 | 0.040 |
Why?
|
| Inflammation | 1 | 2016 | 10637 | 0.030 |
Why?
|
| Atrophy | 1 | 2021 | 1584 | 0.030 |
Why?
|
| Dinoprostone | 2 | 1996 | 601 | 0.030 |
Why?
|
| Levodopa | 1 | 2016 | 219 | 0.030 |
Why?
|
| Zygapophyseal Joint | 1 | 2017 | 129 | 0.030 |
Why?
|
| Injections, Spinal | 1 | 2015 | 303 | 0.030 |
Why?
|
| Interferons | 1 | 1998 | 706 | 0.030 |
Why?
|
| Eicosanoids | 1 | 1996 | 279 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 4 | 1996 | 6313 | 0.030 |
Why?
|
| Lithocholic Acid | 1 | 1994 | 26 | 0.030 |
Why?
|
| Hydrocephalus | 1 | 2021 | 748 | 0.030 |
Why?
|
| Abdominal Cavity | 1 | 2014 | 52 | 0.030 |
Why?
|
| HLA-DR Antigens | 1 | 1995 | 645 | 0.030 |
Why?
|
| Isoflurane | 1 | 2016 | 380 | 0.030 |
Why?
|
| Neck | 1 | 2017 | 698 | 0.030 |
Why?
|
| Lectins, C-Type | 1 | 2016 | 589 | 0.030 |
Why?
|
| Microelectrodes | 1 | 2014 | 303 | 0.030 |
Why?
|
| Natural Language Processing | 1 | 2021 | 1041 | 0.030 |
Why?
|
| Digestive System Diseases | 1 | 2014 | 147 | 0.030 |
Why?
|
| Brain Neoplasms | 1 | 2013 | 8861 | 0.030 |
Why?
|
| Brain | 2 | 2021 | 26388 | 0.030 |
Why?
|
| History, 20th Century | 1 | 1999 | 2740 | 0.020 |
Why?
|
| Patient Discharge | 1 | 2023 | 3318 | 0.020 |
Why?
|
| Warfarin | 1 | 2018 | 1497 | 0.020 |
Why?
|
| Fasting | 1 | 2016 | 1592 | 0.020 |
Why?
|
| Receptors, Immunologic | 1 | 2016 | 1423 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 1999 | 6489 | 0.020 |
Why?
|
| Colon | 2 | 1996 | 1772 | 0.020 |
Why?
|
| Fatal Outcome | 1 | 2013 | 1851 | 0.020 |
Why?
|
| HLA Antigens | 1 | 1994 | 1382 | 0.020 |
Why?
|
| Tomography Scanners, X-Ray Computed | 1 | 2009 | 168 | 0.020 |
Why?
|
| Follow-Up Studies | 2 | 2014 | 39052 | 0.020 |
Why?
|
| Anticoagulants | 1 | 2022 | 4600 | 0.020 |
Why?
|
| Dinoprost | 2 | 1996 | 138 | 0.020 |
Why?
|
| Movement Disorders | 1 | 2009 | 446 | 0.020 |
Why?
|
| Interferon-gamma | 1 | 1994 | 3207 | 0.020 |
Why?
|
| Radiation Dosage | 1 | 2014 | 1928 | 0.020 |
Why?
|
| Medicare | 1 | 2023 | 6566 | 0.020 |
Why?
|
| Globus Pallidus | 1 | 2006 | 253 | 0.020 |
Why?
|
| Antigens, Neoplasm | 1 | 1993 | 1988 | 0.020 |
Why?
|
| Leukotriene B4 | 2 | 1996 | 294 | 0.020 |
Why?
|
| Models, Biological | 1 | 2021 | 9584 | 0.010 |
Why?
|
| Hospitalization | 1 | 2022 | 10259 | 0.010 |
Why?
|
| Gene Expression | 1 | 2016 | 7798 | 0.010 |
Why?
|
| Adenoma | 1 | 1993 | 2174 | 0.010 |
Why?
|
| Intestinal Mucosa | 1 | 1993 | 3037 | 0.010 |
Why?
|
| Neuropsychological Tests | 1 | 2014 | 6994 | 0.010 |
Why?
|
| Adolescent | 2 | 2021 | 85779 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2013 | 10252 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2016 | 9445 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 25039 | 0.010 |
Why?
|
| Functional Laterality | 1 | 2006 | 2290 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2016 | 21748 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2021 | 41005 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2021 | 20130 | 0.010 |
Why?
|
| 16,16-Dimethylprostaglandin E2 | 1 | 1996 | 22 | 0.010 |
Why?
|
| United States | 1 | 2023 | 69872 | 0.010 |
Why?
|
| HLA-C Antigens | 1 | 1994 | 147 | 0.010 |
Why?
|
| HLA-A Antigens | 1 | 1994 | 232 | 0.010 |
Why?
|
| Base Sequence | 2 | 1995 | 12797 | 0.010 |
Why?
|
| HLA-B Antigens | 1 | 1994 | 354 | 0.010 |
Why?
|
| Child | 1 | 2021 | 77709 | 0.010 |
Why?
|
| Cell Line | 2 | 1998 | 16000 | 0.010 |
Why?
|
| Bile Acids and Salts | 1 | 1994 | 368 | 0.010 |
Why?
|
| Carcinoembryonic Antigen | 1 | 1993 | 349 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2013 | 23336 | 0.010 |
Why?
|
| Molecular Sequence Data | 2 | 1995 | 18111 | 0.010 |
Why?
|
| Reference Values | 1 | 1998 | 4982 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2015 | 53290 | 0.010 |
Why?
|
| DNA Primers | 1 | 1995 | 2891 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 1996 | 6386 | 0.000 |
Why?
|
| Down-Regulation | 1 | 1994 | 3001 | 0.000 |
Why?
|
| Polymerase Chain Reaction | 1 | 1995 | 6171 | 0.000 |
Why?
|
| Aspirin | 1 | 1995 | 3283 | 0.000 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1995 | 10943 | 0.000 |
Why?
|
| Transcription, Genetic | 1 | 1994 | 7721 | 0.000 |
Why?
|
| RNA, Messenger | 1 | 1995 | 13035 | 0.000 |
Why?
|
| Immunohistochemistry | 1 | 1993 | 11366 | 0.000 |
Why?
|
| Mice | 1 | 1996 | 81201 | 0.000 |
Why?
|
| Animals | 1 | 1996 | 168768 | 0.000 |
Why?
|